Wissenschaftliche Arbeiten

Doç. Dr. Mesut Ayer

87 Publikationen. Neben jeder Publikation steht die Quelle der Angabe.

Zurück zum Profil
  1. Outcomes of Chronic Myeloid Leukemia Patients With Early Molecular Response at 3 and 6 Months: A Comparative Analysis of Generic Imatinib and Glivec

    Clinical Lymphoma Myeloma and Leukemia, 2017

    DOI 10.1016/j.clml.2017.07.255 PMID 28847475 15 Zitationen (Europe PMC) Quelle: ORCID

  2. Purtscher-Like Retinopathy Associated with Atypical Hemolytic Uremic Syndrome

    Turkish Journal of Ophthalmology, 2017

    DOI 10.4274/tjo.66502 PMID 29326853 18 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  3. The Impact of Mean Platelet Volume (MPV) and JAK-2 Mutation on Thrombosis in Chronic Myeloproliferative Diseases

    Indian Journal of Hematology and Blood Transfusion, 2017

    DOI 10.1007/s12288-016-0685-8 PMID 28596648 10 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  4. Evaluation of Insulin-like Growth Factor-1 and Insulin-like Growth Factor Binding Protein-3 Expression Levels in Patients with Chronic Lymphocytic Leukemia

    Turkish Journal of Hematology, 2016

    DOI 10.4274/tjh.2016.0075 PMID 27094973 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  5. Cox-2 gene polymorphisms in Turkish patients with myelodysplastic syndrome

    Trakya University's Institutional Open Access System (Trakya University), 2016

    Quelle: OpenAlex

  6. USE OF ELTROMBOPAG IN IMMUNE THROMBOCYTOPENIA IN TURKEY

    Istanbul Science University (Istanbul Bilim University), 2016

    Frei zugänglicher VolltextQuelle: OpenAlex

  7. A Case of Ulcerative Colitis Accompanied by Hemolytic Uremic Syndrome

    Turkish Nephrology, Dialysis and Transplantation Journal, 2016

    DOI 10.5262/tndt.2016.16 Frei zugänglicher VolltextQuelle: ORCID

  8. Cutaneous adverse reactions of imatinib therapy in patients with chronic myeloid leukemia: A six-year follow up

    European Journal of Dermatology, 2016

    DOI 10.1684/ejd.2015.2684 PMID 26679005 13 Zitationen (Europe PMC) Quelle: ORCID

  9. Pesg PNH diagnosis, follow-up and treatment guidelines

    American Journal of Blood Research, 2016

    PMID 27570707 49 Zitationen (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  10. Yüksek serum CA 125 düzeyi ile seyreden sistemik lupus eritematozis olgusu

    DergiPark (Istanbul University), 2016

    Frei zugänglicher VolltextQuelle: OpenAlex

  11. The frequency of polyneuropathy and comparison of laboratory parameters in patients with multiple myeloma

    Dicle Medical Journal / Dicle Tip Dergisi, 2015

    DOI 10.5798/diclemedj.0921.2015.04.0606 Frei zugänglicher VolltextQuelle: OpenAlex

  12. An effective treatment of atypical hemolytic uremic syndrome with plasma exchange and eculizumab: A case report

    Transfusion and Apheresis Science, 2015

    DOI 10.1016/j.transci.2015.01.006 PMID 25634788 5 Zitationen (Europe PMC) Quelle: ORCID

  13. Can Positron Emission Tomography and Computed Tomography Be a Substitute for Bone Marrow Biopsy in Detection of Bone Marrow Involvement in Patients with Hodgkin's or Non-Hodgkin's Lymphoma?

    The Turkish Journal of Hematology, 2015

    DOI 10.4274/tjh.2013.0336 PMID 25912844 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  14. GENERIC IMATINIB IN NEWLY DIAGNOSED CHRONIC MYELOID LEUKEMIA (CML) PATIENTS IN CHRONIC PHASE: UPDATED DATA FROM A TURKISH CML COHORT

    Haematologica, 2015

    Quelle: ORCID

  15. OUTCOMES OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH 10%≤AND>10% BCR-ABL1 (IS) TRANSCRIPT LEVELS AFTER 3 MONTHS OF GENERIC IMATINIB TREATMENT

    Haematologica, 2015

    Quelle: ORCID

  16. RAPID EFFICACY OF LENALIDOMIDE PLUS DEXAMETHASONE FOR POEMS SYNDROME: ASSESSMENT OF FOUR PATIENT'S CLINICAL OUTCOME

    Haematologica, 2015

    Quelle: ORCID

  17. Hepatik Ven Trombozunun Nadir Bir Sebebi: Paroksismal Noktürnal Hemoglobinüri

    2015

    Quelle: OpenAlex

  18. PP-087 DO WE REALLY TREAT ESSENTIAL THROMBOCYTHEMIA? A CLINICAL TRIAL OF 148 PATIENTS WITH ET

    Leukemia Research, 2014

    DOI 10.1016/s0145-2126(14)70141-9 Quelle: OpenAlex

  19. Investigation of DNA repair gene variants on myelodysplastic syndromes in a Turkish population

    Medical Oncology, 2014

    DOI 10.1007/s12032-014-0174-6 PMID 25154760 5 Zitationen (Europe PMC) Quelle: OpenAlex

  20. Evaluation of clinical and laboratory findings with JAK2 V617F mutation as an independent variable in essential thrombocytosis.

    Molecular biology reports, 2014

    DOI 10.1007/s11033-014-3559-x PMID 25012914 10 Zitationen (Europe PMC) Quelle: ORCID

  21. A triclonal gammopathy in a relapsing multiple myeloma patient, detected by immunosubtraction method

    Annals of Clinical Biochemistry, 2014

    DOI 10.1177/0004563213512801 PMID 24361990 3 Zitationen (Europe PMC) Quelle: ORCID

  22. FIRST LINE TREATMENT OF CHRONIC PHASE CHRONIC MYELOID LEUKEMIA PATIENTS WITH THE GENERIC FORMULATIONS OF IMATINIB MESYLATE

    Haematologica, 2014

    Quelle: ORCID

  23. First line treatment of chronic phase chronic myeloid leukaemia patients with the generic formulations of imatinib mesylate

    British Journal of Haematology, 2014

    DOI 10.1111/bjh.12937 PMID 24815307 17 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  24. Patients treated with therapeutic plasma exchange: A single center experience

    Transfusion and Apheresis Science, 2014

    DOI 10.1016/j.transci.2014.10.006 PMID 25457747 8 Zitationen (Europe PMC) Quelle: ORCID

  25. Surgical Splenectomy Indications in Benign and Malignant Splenic Diseases and the Role of Minimally Invasive Surgery

    Istanbul Medical Journal, 2013

    DOI 10.5152/imj.2013.23 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: ORCID

  26. Tiroid Fonksiyon Bozukluğu Bulunan Hastalarda Erken Dönem Kardiyak Disfonksiyonu Belirlemede N-Terminal Pro-B-Tip Natriüretik Peptid

    Medical Bulletin of Haseki, 2013

    DOI 10.4274/haseki.1011 1 Zitation (OpenAlex) Frei zugänglicher VolltextQuelle: OpenAlex

  27. Febrile Neutropenia Due To Brucellosis: Case Report

    DOAJ (DOAJ: Directory of Open Access Journals), 2012

    Frei zugänglicher VolltextQuelle: OpenAlex

  28. Comparison of Heart Type Free Fatty Acid Binding Protein, CPK-MB and Troponin-I in the early diagnosis of acute coronary syndrome

    Kafkas Journal of Medical Sciences, 2012

    DOI 10.5505/kjms.2012.42714 Frei zugänglicher VolltextQuelle: OpenAlex

  29. Sweet's Syndrome Accompanying Acute Myelomonocytic Leukemia (AML FAB-M4)-A Case Report

    DOAJ (DOAJ: Directory of Open Access Journals), 2010

    Frei zugänglicher VolltextQuelle: OpenAlex

  30. AKUT MYELOİD LÖSEMİ TANISINDAN ÖNCE ORTAYAÇIKAN VE LENFOMAİLE KARIŞABİLEN GRANULOSİTİK SARKOM

    DergiPark (Istanbul University), 2009

    DOI 10.18017/itfd.84171 Frei zugänglicher VolltextQuelle: OpenAlex

  31. Atypical M-Protein Localization in Protein Electrophoresis in a Patient With Multiple Myeloma

    DergiPark (Istanbul University), 2008

    2 Zitationen (OpenAlex) Quelle: OpenAlex

  32. Leukocytoclastic Vasculitis due to Thalidomide in Multiple Myeloma

    Japanese Journal of Clinical Oncology, 2007

    DOI 10.1093/jjco/hym092 PMID 17709605 15 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

  33. CLINICAL FOLLOW-UP AND TREATMENT RESPONSE OF THE 162 PATIENTS WITH CHRONIC IDIOPATHIC THROMBOCYTOPENIC PURPURA

    İstanbul Tıp Fakültesi Dergisi, 2007

    Quelle: OpenAlex

  34. Does Previous Interferon Use Have Negative Effect on Imatinib Response in Chronic Myeloid Leukemia (CML)? A Single Center Study.

    Blood, 2006

    DOI 10.1182/blood.v108.11.4821.4821 Quelle: OpenAlex

  35. A case of myelodysplastic syndrome with erythroid hypoplasia associated with a familial translocation t(3;14)(p21.1;q24.1)

    American Journal of Hematology, 2006

    DOI 10.1002/ajh.20684 PMID 16888788 4 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: ORCID

  36. High-dose exposure to valsartan with suicidal intention

    International Journal of Clinical Pharmacology and Therapeutics, 2004

    DOI 10.5414/cpp42328 PMID 15222725 2 Zitationen (Europe PMC) Quelle: ORCID

  37. The effect of diabetes mellitus on ischemic preconditioning and myocardial damage in myocardial infarction

    Diabetologia, 2003

    Quelle: ORCID